Activity-Based Intervention to Address Cannabis Use
A Remote Behavioral Economics-Based Intervention for Cannabis Use Disorder: Bridging Gaps in Care
2 other identifiers
interventional
300
1 country
1
Brief Summary
This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2027
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2026
CompletedFirst Posted
Study publicly available on registry
September 10, 2026
CompletedStudy Start
First participant enrolled
February 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2030
Study Completion
Last participant's last visit for all outcomes
September 1, 2030
September 14, 2026
September 1, 2026
3.6 years
September 4, 2026
September 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Cannabis use
Change in frequency of cannabis use measured by the Timeline Follow Back
3-, 6-, 12-months
Secondary Outcomes (3)
Cannabis use disorder symptoms
3-, 6-, 12-months
Depressive symptoms
3-, 6-, 12-months
Anxiety symptoms
3-, 6-, 12-months
Study Arms (2)
MI-BE
EXPERIMENTALEUC
ACTIVE COMPARATORInterventions
6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement.
Eligibility Criteria
You may qualify if:
- current cannabis use disorder
- active cannabis use,
- camera/technology/phone access
- able to give informed consent.
You may not qualify if:
- inability to speak English
- conditions precluding informed consent, full participation, or understanding of interventions/assessments
- past 90-day cannabis use disorder/substance use disorder treatment
- current cancer treatment
- medical cannabis certification for current cancer, end-of-life care, or progressive debilitating disease
- active moderate/severe other substance use disorder(s) or injection drug use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Michigan, Ann Arbor, Michigan 48109
Ann Arbor, Michigan, 48109, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Bonar, PhD
University of Michigan
- PRINCIPAL INVESTIGATOR
Lara Coughlin, PhD
University of Michigan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry
Study Record Dates
First Submitted
September 4, 2026
First Posted
September 10, 2026
Study Start (Estimated)
February 1, 2027
Primary Completion (Estimated)
September 1, 2030
Study Completion (Estimated)
September 1, 2030
Last Updated
September 14, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share